Knockdown of Osteopontin Reduces the Inflammatory Response and Subsequent Size of Postsurgical Adhesions in a Murine Model  by Andrews, Stuart et al.
The American Journal of Pathology, Vol. 181, No. 4, October 2012
Copyright © 2012 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ajpath.2012.06.027Short Communication
Knockdown of Osteopontin Reduces the
Inflammatory Response and Subsequent Size of
Postsurgical Adhesions in a Murine ModelStuart Andrews,* Debi Ford,* and Paul Martin*†
From the Departments of Physiology/Pharmacology* and
Biochemistry,† University of Bristol, Bristol, United Kingdom
Adhesions between organs after abdominal surgery
remain a significant unresolved clinical problem,
causing considerable postoperative morbidity. Osteo-
pontin (OPN) is a cytokine up-regulated after cell in-
jury and tissue repair. Our previous studies have
shown that blocking OPN expression at sites of cuta-
neous wounding resulted in reduced granulation tis-
sue and scarring. We hypothesize that it may be pos-
sible to similarly reduce inflammation-associated
fibrosis that causes small-bowel adhesions after ab-
dominal surgery. By using a mouse model, we deliver
OPN antisense oligodeoxynucleotides via Pluronic gel
to the surface of injured, juxtaposed small bowel and
show a significant reduction of inflammatory cell in-
flux to the developing adhesion and a dramatic reduc-
tion in the resulting adhesion size. A significant re-
duction in -smooth muscle actin expression and
collagen deposition within the mature adhesion is
also demonstrated. We see no impact on mortality,
and the healing of serosal injury to intact bowel ap-
peared normal given the reduced inflammatory re-
sponse. Our studies suggest that dampening OPN lev-
els might be a potentially important target for anti-
adhesion therapeutics. (Am J Pathol 2012, 181:1165–
1172; http://dx.doi.org/10.1016/j.ajpath.2012.06.027)
The peritoneum is an extensive and complex organ con-
sisting of a layer of mesothelial cells lining the peritoneal
cavity and all organs within it.1 One of the main functions
of the peritoneum is to allow friction-free movement be-
tween abdominal viscera and the peritoneal wall.2 Any
surgery that breaches the peritoneal lining causes injury
to the peritoneum, which responds by raising inflamma-
tory signals that attract innate immune cells in parallel
with a wound repair response and subsequent fibro-
sis.3–5 This almost invariably results in permanent perito-neal adhesion formation.6 The result can be tethering of
adjacent small-bowel loops that may lead to abdominal
pain7 and/or bowel obstruction,8 which is a significant
cause of postoperative morbidity in clinical practice. Re-
admission rates secondary to adhesional complications
are as high as 5% to 10% after abdominal surgery.9,10
Adhesion prevention options in clinical practice are lim-
ited to either barrier methods11 or flotation fluids,12 which
use the concept of keeping damaged peritoneal surfaces
separated during their healing process; however, these
options are of limited effectiveness.13,14 Pathophysiolog-
ical manipulation of the cascade events leading to fibro-
sis has been investigated,15–18 but none has led to a
clinically usable product. Herein, we investigate whether
therapeutic strategies used to block scar formation after
skin healing might also be effective during peritoneal
repair. Microarray studies of wound tissues from wild-
type mice versus PU.1 mice (lacking neutrophils, macro-
phages, and mast cells) reveal an inflammation-depen-
dent gene, osteopontin (OPN), that is expressed by
wound granulation tissue fibroblasts, coincident with a
skin wound inflammatory response.19,20 PU.1 mice heal
skin wounds without the standard inflammatory cascade,
which results in less fibrosis and scarring at the healed
wound site.19 OPN acts both as a secreted chemokine-
like protein and as part of an intracellular signaling com-
plex.21 It plays key roles in several processes associated
with tissue repair, including cell adhesion, migration, and
survival.21,22 Short-term local knockdown of OPN in cu-
taneous wounds leads to decreased granulation tissue
and reduced scar formation.23 In this study, we investi-
gate whether these effects are transferable to peritoneal
repair and also might block i.p. fibrosis.
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Interloop Small-Bowel Adhesion Model and
OPN Suppression
All experiments were performed after local ethical ap-
proval and conducted according to University of Bristol
(Bristol, Somerset, UK) and UK Home Office regulations.
A total of 59 mice (CD-1 age-matched males, aged 8 to
11 weeks) were used for this study. Mice were anesthe-
tized with isoflurane, their abdominal wall was shaved,
and the peritoneal cavity was entered aseptically through
a 20-mm midline incision (Figure 1A). At mid small-bowel
level, a loop of small bowel was selected and folded back
into a juxtaposed position (Figure 1B). The serosal sur-
faces of the bowel that fell in contact were injured by
scalpel abrasion over a length of 10 mm, limited at each
end by two 7/0 Prolene (polypropylene) sutures that held
the bowel in apposition (Figure 1C). The linea alba was
closed with four interrupted 5/0 Prolene sutures, and skin
was closed with five interrupted 5/0 Prolene sutures. The
day 7 result shows fusion of the injured bowel sections
(Figure 1D). Down-regulation of OPN expression at the
wound site was achieved by mRNA depletion with OPN
antisense (AS) oligodeoxynucleotides (ODNs). The opti-
mal AS sequence against murine OPN (5=-ACTATCGAT-
CACATCCG-3=) was the same as used in our previous
successful study on cutaneous wounds.21 A scrambled-
sequence ODN (5=-CGGATGTGATCGATAGT-3=) was
used as a further control (C ODN group). Pluronic F-127
gel (Sigma-Aldrich, Gillingham, UK), which is in liquid
state at 5°C and solidifies at 15°C, was used as the
carrying vehicle for delivery of ODNs (5 mol/L ODN in
20 L of 30% Pluronic F-127 gel). Mice were randomized
(shuffled card selection) after bowel surface abrasion to
receive the following: no treatment (group C, 15 mice),
control ODN (group C ODN, 15 mice), or antisense ODN
(group AS ODN, 15 mice). Gel treatments were applied
topically at 4°C by pipette between bowel surfaces be-
fore suturing into apposition. The mice were subse-
quently sacrificed at 1, 3, and 7 days, respectively, post-
operatively for tissue harvest (n  5 at each time point).
Both preoperative and postoperative mice were main-
tained under standard conditions of food and water ad
libitum on a 12-hour day-night cycle.
Histological Features
Tissue was fixed in 4% paraformaldehyde for embedding
in paraffin. Transverse sections (7 m thick) were cut.
Each mouse interloop adhesion was sectioned at the
midpoint between sutures (mid adhesion point), and 10
of these sections were chosen at random for staining.
Leukocyte recruitment was quantified by determining
neutrophil/macrophage cell densities within the adhesion
(ie, leukocyte count, blinded and double verified) per unit
cross-sectional area of adhesion (measured using Image
J software, NIH, Bethesda, MD). Neutrophils were
stained with anti-myeloperoxidase antibody (Thermo Sci-
entific, Hemel Hempstead, UK), 1:200; and secondary
goat biotinylated anti-rabbit IgG (Dako, Glostrup, Den-mark), 1:400; macrophages were revealed by immuno-
staining with F4/80 antibody (Abcam), 1:400; and sec-
ondary rabbit biotinylated anti-rat IgG (Dako, Cambridge,
UK) antibody, 1:400. To determine adhesional tissue ex-
tent (cross-sectional area), we stained with Masson’s
trichrome; collagen within the adhesion was stained with
picrosirius red; and -smooth muscle actin (-SMA)-–
positive cells were revealed by immunostaining with
-SMA antibody (Abcam), 1:400, and secondary rabbit
biotinylated anti-rat IgG (Dako) antibody, 1:400. Trans-
forming growth factor (TGF) 1 protein was identified with
TGF 1 antibody (Abcam), 1:800; and secondary goat
biotinylated anti-rabbit IgG (Dako) antibody, 1:400.
-SMA, collagen, and TGF 1 staining intensity was mea-
sured by adhesion outline mapping, background sub-
traction, and pixel quantification (Image J software) and
expressed as adhesion stain density.
Western Blot Analysis
Tissue samples for Western blot analysis were dissected
under a microscope to include only the adhesional tissue
and the bowel wall intimately related to the adhesion (n
3 in each group). The prepared tissue was snap frozen in
liquid nitrogen. Samples were resuspended in radioim-
munoprecipitation assay lysis buffer at 4°C, homoge-
nized and subsequently centrifuged at 13,000 rpm for 10
minutes. Protein concentrations were estimated using a
BCA Protein assay kit (Thermo Scientific). Protein sam-
ples were separated on Tris-Glycine Gels (Invitrogen,
Paisley, UK) and transferred to polyvinylidene difluoride.
Blotted samples were reacted with OPN Ab, 1:2500 (R&D
Systems, Abingdon, UK); 5% milk blocking, and -goat
horseradish peroxidase (Jackson Labs, West Grove, PA)
secondary Ab, 1:5000. Glyceraldehyde-3-phosphate de-
hydrogenase, 1:5000, was used for control. The resulting
blots were developed with Luminol Enhancer solution
(Biological Industries, Beit-Haemek, Israel), and densito-
metric analysis was performed with Image J software.
Statistical Analysis
Data are shown as the mean  SEM, with statistical
analysis performed using an unpaired t-test (StatistiXL,
version 1.8; http://www.statistixl.com). In all tests, P 
0.05 was considered significant.
Results
As previously reported,24 suturing together bowel loops
after light abrasion to the mesothelial covering led to
reproducible formation of an adhesion between the two
opposing bowel segments involved (Figure 1E). By 7
days, the peritoneal abrasions were considered healed
by the presence of an intact mesothelial layer covering
the surface of the adhesional tissue in continuity with that
of the serosal surface of the associated bowel (Figure
1F). As expected, we observed a locally increased for-
eign body inflammatory response and associated adhe-
sional tissue deposition by the sutures (Figure 1G); there-
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AJP October 2012, Vol. 181, No. 4Figure 1. Damage to bowel serosa within the peritoneum leads to adhesion formation, influx of leukocytes, and transient OPN induction. A: Schematic showing
mouse peritoneum opened. B: Selection of small-bowel loop for injury. Scale bar  2 mm. C: Suturing small bowel to hold injured surfaces in apposition. D:
Appearance of the resulting interloop small-bowel adhesion at day 7. E: Masson’s trichrome stain of day 7 adhesion at mid adhesion point, cross section. Scale
bar  200 m. F (inset for E): Healed lesion with mesothelial covering (arrows) in continuity with bowel. Scale bar  50 m. G: Increased adhesional tissue
related to suture (arrow). Inset: F4/80 macrophage immunostain showing inflammatory reaction to suture. H: Masson’s trichrome stain of adhesion evolution
at 1, 3, and 7 days. Scale bar  100 m. I: Immunostaining for presence of neutrophils (myeloperoxidase). J: Macrophages (F4/80). Adjacent graphs report
neutrophil/macrophage density flux in maturing adhesion as seen in I and J. Data are given as mean  SEM (n  5). K: Western blot analysis of OPN levels
confirms absence in uninjured tissue, early up-regulation after wounding, with subsequent resolution by day 7. Data are given as mean  SEM band intensity
(n  3). GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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these holding sutures (mid adhesion point).
During the time points considered, the evolving adhe-
sion morphological features, cellular flux, matrix deposi-
tion, and resolution were demonstrated (Figure 1H). Im-
munostaining of injured bowel sections revealed an influx
of neutrophils to the developing adhesional tissue, from
almost zero in immediately injured and fixed tissue (data
not shown) to a peak at day 1 and subsequent resolution
by day 7 (Figure 1I). Immunostaining for macrophages
revealed a somewhat later influx of macrophages, with
their density peaking and then resolving from 3 days
(Figure 1J). This untreated/control group (C) reproduced
previously published leukocyte temporal and spatial pat-
terns of recruitment after peritoneal injury.25
Because of our previous observations in healing skin
wounds that revealed how inflammatory cell recruitment
leads to induction of OPN by the wound fibroblasts,23 we
investigated whether the same might be true in develop-
ing peritoneal adhesions. Our Western blot analysis indi-
cated that up-regulation of OPN coincided with the influx
of inflammatory cells to developing adhesions. We no-
ticed an absence of OPN in uninjured tissue, but there
was a transient flux between 1 and 3 days, and subse-
quent resolution by day 7 (Figure 1K).
Leukocyte Recruitment Is Significantly Reduced
in OPN AS ODN-Treated Adhesions
To address whether there was a functional link between
OPN expression and immune cell recruitment, we
knocked down OPN at the lesion site by local release of
AS, specifically targeted against OPN, and delivered at
bowel injury. Western blot analysis reproducibly showed
AS treatment knocked down OPN levels by at least 50%
compared with the control lesions during the previously
demonstrated peak OPN flux (Figure 2A).
At all three time points examined (1, 3, and 7 days), we
observed a significant (P  0.05) reduction in density of
both neutrophils and macrophages within the developing
adhesion after OPN knockdown compared with both C
(untreated) and C ODN groups (Figure 2, B and C). We
saw no significant difference in neutrophil/macrophage
density at any time points between both control groups (P
 0.05).
Adhesion Size Is Significantly Reduced in OPN
Knockdown Lesions
We found a significant (P  0.05) reduction in adhesion
size (microscopic cross-sectional area) at all stages of
adhesion development in our AS ODN-treated group
compared with the C ODN group as they tended toward
resolution of inflammation and ultimate fibrosis at day 7
(Figure 3A). This was also true of AS ODN-treated lesions
compared with untreated lesions (C), with the exception
of day 1, which fell just outside significance (P  0.052).
The day 7 macroscopic findings (Figure 3B) showed a
less fused appearance of AS ODN-treated bowel com-
pared with controls, which were also more flimsy to dis-section than the controls. This difference was reflected in
the microscopic cross-sectional appearance of adhe-
sions at day 7 (Figure 3C).
-SMA and Collagen Deposition Is Significantly
Reduced in OPN Knockdown Lesions
-SMA immunostaining for myofibroblasts was absent
within the adhesion at 24 hours, minimal at day 3, and
extensive throughout the adhesion by day 7 (Figure 3D);
the intensity of -SMA was, therefore, examined in our
day 7 AS ODN-treated lesions compared with controls
(Figure 3E). A considerable reduction in stain intensity
was apparent in treatment lesions compared with both
controls and was significant after objective quantification
(P  0.05). Because we knew that myofibroblast induc-
tion at sites of tissue repair was also a downstream con-
sequence of TGF 1 expression,20 we investigated TGF
1 levels during development of adhesions and found
that these were highest at day 3 (Figure 3F). However,
even with OPN suppression, our immunostaining studies
indicated little change in TGF 1 protein levels at this time
point (Figure 3G), with no significant difference between
treatment lesions compared with controls (P  0.05).
However, collagen deposition within adhesions exam-
ined at day 7 (Figure 3H) was significantly reduced (P 
0.05) in treatment lesions.
AS treatment did not appear to observably delay the
time course of mesothelial healing, and an intact meso-
thelial layer was observed over the adhesion, in continuity
with bowel serosa at day 7 in all groups. In addition, there
was no measurable morbidity or mortality in any of the
groups.
Discussion
To our knowledge, this study provides the first demon-
stration of OPN up-regulation within developing interloop
bowel adhesions after peritoneal injury. Our in vivo exper-
iments indicate that local down-regulation of OPN by
delivery of AS treatment to the exact site and at the time
of injury has a dramatic effect on the inflammatory re-
sponse, leading to a reduction of influx of both neutro-
phils and macrophages. This suggests that OPN may, in
part, function as a chemoattractant and/or inflammatory
amplification signal for neutrophil and macrophage re-
cruitment to sites of tissue injury. The early OPN response
to injury, coupled with the observation that reduction in
adhesion size appears more pronounced with time, sug-
gests that OPN suppression casts an increasing down-
stream legacy in terms of fibrosis that may account for the
initial lack of size significance between C and AS ODN
groups at day 1. We suspect that OPN suppression le-
sions are initially smaller because of reduced matrix de-
position and, later, secondary to reduced fibroblast re-
cruitment and collagen deposition. This also supports our
findings of more flimsy adhesions in these treated le-
sions. The observed effect of adhesion contraction be-
tween day 3 and day 7 in all groups is likely to be a
consequence of the synchronous appearance of -SMA
rophage
5). GAP
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lated to myofibroblast influence.
Surprisingly, it appears that OPN knockdown does not
Figure 2. AS ODNs against OPN efficiently decrease OPN levels and reduce
confirms significant down-regulation in AS ODN groups at days 1 and 3 comp
B: Immunostaining of neutrophil influx intensity (scale bar  100 m) of the
density. Data are given as mean  SEM (n  5). C: Immunostaining of mac
AS ODN shows significant inhibition. Data are given as mean  SEM (n dramatically reduce TGF 1 levels at the adhesion site, atleast at the time point we observed. Yet, collagen levels
are subsequently reduced, suggesting that there is either
a temporal dampening down of TGF 1 here (eg, as in
yte cell density in murine adhesions. A: Western blot analysis of OPN levels
h both control groups. Data are given as mean SEM band intensity (n 3).
g adhesion, and graph C versus C ODN versus AS ODN significantly inhibits
influx density of the evolving adhesion, and graph C versus C ODN versus
DH, glyceraldehyde-3-phosphate dehydrogenase. ***P  0.01.leukoc
ared wit
evolvinembryonic skin healing)27 or alternative signaling routes
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AJP October 2012, Vol. 181, No. 4Figure 3. OPN suppression significantly reduces adhesion size, -SMA, and collagen deposition in treated lesions. A: Adhesion extent, average cross-sectional area between
C, CODN, andASODNat 1, 3, and 7 days, indicates significantly reduced adhesion size in the treated group. Data are given asmean SEM (n 5).B:Macroscopic appearance
of interloop small-bowel adhesion at day 7 in C, CODN, and ASODN groups.C:Masson’s trichrome stain of adhesion extent at day 7 for C versus CODN versus ASODN. Scale
bar 200 m. D: -SMA expression in untreated adhesions at time points. Inset: High-power magnification of adhesion. Scale bar 200 m. E: Comparison of -SMA stain
intensity for lesions at day 7. Adjacent graph reports -SMA staining intensity in control versus AS ODN treatment groups. F: TGF 1 expression in untreated adhesions at time
points.G:Comparison of TGF1 stain intensity for lesions at day 3. Scale bar 50m.H:Comparison of collagen stain intensity for lesions at day 7, and adjacent graph C versus
C ODN versus AS ODN, shows significant reduction.
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support the latter, OPN suppression reduces the ability of
TGF 1 to stimulate the expression of myofibroblast
-SMA.28 This might explain why attenuation of OPN in
isolation produced such dramatic reduction of myofibro-
blast activation, as indicated by reduced -SMA and
collagen in treatment lesions.
We observed no difference between control groups (C
and C ODN) with respect to leukocyte density, adhesion
size, -SMA, or collagen deposition, demonstrating that
the Pluronic gel delivery agent itself was not inhibiting
adhesion formation by a barrier effect or had any inherent
anti-adhesiogenic properties. The parallels with previ-
ously published studies that demonstrated OPN suppres-
sion in cutaneous wounds leads to reduced fibrosis with-
out retarding healing23 are clearly apparent. OPN is only
one of a portfolio of inflammation-dependent genes
that have been subject to investigation as potential
therapeutic targets for blocking scarring at skin wound
sites; it joins TGF 1 as a conserved mediator of in-
flammation-triggered fibrosis across several tis-
sues.15,16 As a result, it is possible that combinational
therapy targeting both OPN and TGF  might yield
even more beneficial results.
It is still unclear how reducing OPN levels in skin
wounds or developing peritoneal adhesions leads to re-
duction in scarring/adhesion at the site of repair. In skin
wounds, OPN is expressed by infiltrating macrophages
and by wound granulation tissue fibroblasts; thus, knock-
down may be acting, in part, by damping the wound
inflammatory response and, more directly, by altering the
way in which fibroblasts deposit collagen at the wound
site.23 In the current study, we knocked down OPN by
depletion of mRNA with antisense oligodeoxynucle-
otides, but there are other potential strategies that might
be more therapeutically translatable (eg, delivery of syn-
decan 4, which blocks the integrin-binding domain of
OPN and, thus, inactivates the OPN); this strategy has
already proved effective for reducing inflammation-trig-
gered liver fibrosis in rats.29
From our studies, it is logical to consider that OPN
suppression might have potential value in the clinical
practice of adhesion management. The effects of these
experiments are demonstrated in a much localized man-
ner. However, clearly for the observed beneficial effect of
OPN suppression to be realized in the sporadic adhesion
pattern seen in clinical practice, application of AS thera-
peutics would need to be diffuse within the peritoneal
cavity. Previous studies have suggested that tissue repair
is not dependent on inflammation.19 Indeed, the perito-
neal abrasions we generate to trigger the adhesion re-
sponse appear to heal just as well in the reduced inflam-
mation environment of OPN knockdown, but these
experiments were conducted on intact bowel. Possibly, if
surgery were to incur full-thickness injury to the bowel, or
a bowel anastomosis, then the presence of significant
microbial contamination might require a more robust in-
flammatory response and would render inflammation
suppression potentially dangerous.Acknowledgments
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